Paweł Sztromwasser
University of Bergen
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Paweł Sztromwasser.
Nature Genetics | 2015
Karianne Fjeld; Frank Ulrich Weiss; Denise Lasher; Jonas Rosendahl; Jian-Min Chen; Bente B. Johansson; Holger Kirsten; Claudia Ruffert; Emmanuelle Masson; Solrun J. Steine; Peter Bugert; Miriam Cnop; Robert Grützmann; Julia Mayerle; Joachim Mössner; Monika Ringdal; Hans-Ulrich Schulz; Matthias Sendler; Peter Simon; Paweł Sztromwasser; Janniche Torsvik; Markus Scholz; Erling Tjora; Claude Férec; Heiko Witt; Markus M. Lerch; Pål R. Njølstad; Stefan Johansson
Carboxyl ester lipase is a digestive pancreatic enzyme encoded by the CEL gene. Mutations in CEL cause maturity-onset diabetes of the young as well as pancreatic exocrine dysfunction. Here we describe a hybrid allele (CEL-HYB) originating from a crossover between CEL and its neighboring pseudogene, CELP. In a discovery series of familial chronic pancreatitis cases, we observed CEL-HYB in 14.1% (10/71) of cases compared to 1.0% (5/478) of controls (odds ratio (OR) = 15.5; 95% confidence interval (CI) = 5.1–46.9; P = 1.3 × 10−6 by two-tailed Fishers exact test). In three replication studies of nonalcoholic chronic pancreatitis, we identified CEL-HYB in a total of 3.7% (42/1,122) cases and 0.7% (30/4,152) controls (OR = 5.2; 95% CI = 3.2–8.5; P = 1.2 × 10−11; formal meta-analysis). The allele was also enriched in alcoholic chronic pancreatitis. Expression of CEL-HYB in cellular models showed reduced lipolytic activity, impaired secretion, prominent intracellular accumulation and induced autophagy. These findings implicate a new pathway distinct from the protease-antiprotease system of pancreatic acinar cells in chronic pancreatitis.
Diabetologia | 2017
Bente B. Johansson; Henrik Irgens; Janne Molnes; Paweł Sztromwasser; Ingvild Aukrust; Pétur Benedikt Júlíusson; Oddmund Søvik; Shawn Levy; Torild Skrivarhaug; Geir Joner; Stefan Johansson; Pål R. Njølstad
Aims/hypothesisMODY can be wrongly diagnosed as type 1 diabetes in children. We aimed to find the prevalence of MODY in a nationwide population-based registry of childhood diabetes.MethodsUsing next-generation sequencing, we screened the HNF1A, HNF4A, HNF1B, GCK and INS genes in all 469 children (12.1%) negative for both GAD and IA-2 autoantibodies and 469 antibody-positive matched controls selected from the Norwegian Childhood Diabetes Registry (3882 children). Variants were classified using clinical diagnostic criteria for pathogenicity ranging from class 1 (neutral) to class 5 (pathogenic).ResultsWe identified 58 rare exonic and splice variants in cases and controls. Among antibody-negative patients, 6.5% had genetic variants of classes 3–5 (vs 2.4% in controls; p = 0.002). For the stricter classification (classes 4 and 5), the corresponding number was 4.1% (vs 0.2% in controls; p = 1.6 × 10−5). HNF1A showed the strongest enrichment of class 3–5 variants, with 3.9% among antibody-negative patients (vs 0.4% in controls; p = 0.0002). Antibody-negative carriers of variants in class 3 had a similar phenotype to those carrying variants in classes 4 and 5.Conclusions/interpretationThis is the first study screening for MODY in all antibody-negative children in a nationwide population-based registry. Our results suggest that the prevalence of MODY in antibody-negative childhood diabetes may reach 6.5%. One-third of these MODY cases had not been recognised by clinicians. Since a precise diagnosis is important for treatment and genetic counselling, molecular screening of all antibody-negative children should be considered in routine diagnostics.
Embo Molecular Medicine | 2016
Dario Brunetti; Janniche Torsvik; Cristina Dallabona; Pedro Filipe Teixeira; Paweł Sztromwasser; Erika Fernandez-Vizarra; Raffaele Cerutti; Aurelio Reyes; Carmela Preziuso; Giulia d'Amati; Enrico Baruffini; Carlo Viscomi; Ileana Ferrero; Helge Boman; Wenche Telstad; Stefan Johansson; Elzbieta Glaser; Per M. Knappskog; Massimo Zeviani; Laurence A. Bindoff
Mitochondrial dysfunction and altered proteostasis are central features of neurodegenerative diseases. The pitrilysin metallopeptidase 1 (PITRM1) is a mitochondrial matrix enzyme, which digests oligopeptides, including the mitochondrial targeting sequences that are cleaved from proteins imported across the inner mitochondrial membrane and the mitochondrial fraction of amyloid beta (Aβ). We identified two siblings carrying a homozygous PITRM1 missense mutation (c.548G>A, p.Arg183Gln) associated with an autosomal recessive, slowly progressive syndrome characterised by mental retardation, spinocerebellar ataxia, cognitive decline and psychosis. The pathogenicity of the mutation was tested in vitro, in mutant fibroblasts and skeletal muscle, and in a yeast model. A Pitrm1+/− heterozygous mouse showed progressive ataxia associated with brain degenerative lesions, including accumulation of Aβ‐positive amyloid deposits. Our results show that PITRM1 is responsible for significant Aβ degradation and that impairment of its activity results in Aβ accumulation, thus providing a mechanistic demonstration of the mitochondrial involvement in amyloidotic neurodegeneration.
European Journal of Neurology | 2016
Omar Hikmat; Charalampos Tzoulis; Per M. Knappskog; Stefan Johansson; Helge Boman; Paweł Sztromwasser; Espen Lien; Eylert Brodtkorb; Daniele Ghezzi; Laurence A. Bindoff
Defects of coenzyme Q10 (CoQ10) metabolism cause a variety of disorders ranging from isolated myopathy to multisystem involvement. ADCK3 is one of several genes associated with CoQ10 deficiency that presents with progressive cerebellar ataxia, epilepsy, migraine and psychiatric disorders. Diagnosis is challenging due to the wide clinical spectrum and overlap with other mitochondrial disorders.
PLOS ONE | 2016
Irene H. Flønes; Paweł Sztromwasser; Kristoffer Haugarvoll; Christian Dölle; Maria Lykouri; Thomas Schwarzlmüller; Inge Jonassen; Hrvoje Miletic; Stefan Johansson; Per M. Knappskog; Laurence A. Bindoff; Charalampos Tzoulis
Background Biotin-thiamine responsive basal ganglia disease is a severe, but potentially treatable disorder caused by mutations in the SLC19A3 gene. Although the disease is inherited in an autosomal recessive manner, patients with typical phenotypes carrying single heterozygous mutations have been reported. This makes the diagnosis uncertain and may delay treatment. Methods and Results In two siblings with early-onset encephalopathy dystonia and epilepsy, whole-exome sequencing revealed a novel single heterozygous SLC19A3 mutation (c.337T>C). Although Sanger-sequencing and copy-number analysis revealed no other aberrations, RNA-sequencing in brain tissue suggested the second allele was silenced. Whole-genome sequencing resolved the genetic defect by revealing a novel 45,049 bp deletion in the 5’-UTR region of the gene abolishing the promoter. High dose thiamine and biotin therapy was started in the surviving sibling who remains stable. In another patient two novel compound heterozygous SLC19A3 mutations were found. He improved substantially on thiamine and biotin therapy. Conclusions We show that large genomic deletions occur in the regulatory region of SLC19A3 and should be considered in genetic testing. Moreover, our study highlights the power of whole-genome sequencing as a diagnostic tool for rare genetic disorders across a wide spectrum of mutations including non-coding large genomic rearrangements.
American Journal of Ophthalmology | 2015
Cecilie Bredrup; Stefan Johansson; Laurence A. Bindoff; Paweł Sztromwasser; Jostein Kråkenes; Anne E.C. Mellgren; Kari Røine Brurås; Ola Lind; Helge Boman; Per M. Knappskog; Eyvind Rødahl
PURPOSE To investigate the ocular and neurologic manifestations, and to identify the causative mutation in a family with an excavated optic disc anomaly, high myopia, enlarged axial lengths, and abnormal visual evoked response (VER). DESIGN Prospective observational case series with whole exome sequencing. METHODS Institutional study of 8 family members from 3 generations. Clinical examination included visual field examination, optical coherence tomography, axial length measurement, audiometry, visual evoked response (VER), orbital and cerebral magnetic resonance imaging (MRI), and renal ultrasound. DNA was analyzed by whole exome sequencing and Sanger sequencing. Main outcome measures were clinical and radiological findings, and DNA sequence data. RESULTS Three affected family members, a father and his 2 daughters, were examined. The parents and siblings of the father were healthy. Affected individuals presented with excavated optic discs, high myopia (-1.00 to -16.00 diopters), and increased axial lengths. Reduced visual acuity (0.05-0.8) and decreased sensitivity on visual field examination were observed. VER revealed prolonged latency times. Affected eyes appeared ovoid on MRI and the father had thin optic nerves. Exome sequencing revealed that the father was heterozygous for a de novo 5 bp deletion in MYCBP2, c.5906_5910del; p.Glu1969Valfs*26. The same mutation was found in his 2 affected daughters, but not in his parents or siblings, or in public databases. CONCLUSION We describe a distinct excavated optic disc anomaly associated with high myopia and increased axial length. The condition appears to follow an autosomal dominant pattern and segregate with a deletion in MYCBP2. We suggest naming this entity high myopia-excavated optic disc anomaly.
The Cerebellum | 2017
Charalampos Tzoulis; Paweł Sztromwasser; Stefan Johansson; Ivar Otto Gjerde; Per M. Knappskog; Laurence A. Bindoff
We identified PNKP mutations in a Norwegian woman with AOA. This patient had the typical findings with cognitive dysfunction, peripheral neuropathy, cerebellar dysarthria, horizontal nystagmus, oculomotor apraxia, and severe truncal and appendicular ataxia. In addition, she had hypoalbuminemia and massive lower limb edema which showed some improvement with treatment. Exome sequencing identified two heterozygous mutations, one in exon 14 (c.1196T>C, p.Leu399Pro) and one in exon 16 (c.1393_1396del, p.Glu465*). This is the first non-Portuguese patient with AOA due to PNKP mutations and provides independent verification that PNKP mutations cause AOA.
information integration and web-based applications & services | 2012
Sattanathan Subramanian; Paweł Sztromwasser; Kjell Petersen; Pål Puntervoll
In scientific data analysis, workflows are used to integrate and coordinate resources such as databases and tools. Workflows are normally executed by an orchestrator that invokes component services and mediates data transport between them. Scientific data are frequently large, and brokering large data increases the load on the orchestrator and reduces workflow performance. To remedy this problem, we demonstrate how plain SOAP web services can be tailored to support direct service-to-service data transport, thus allowing the orchestrator to delegate the data-flow. We formally define a data-flow delegation message, develop an XML schema for it, and analyze performance improvement of data-flow delegation empirically in comparison with the regular orchestration using an example bioinformatics workflow.
Journal of Integrative Bioinformatics | 2011
Paweł Sztromwasser; Pål Puntervoll; Kjell Petersen
Biological databases and computational biology tools are provided by research groups around the world, and made accessible on the Web. Combining these resources is a common practice in bioinformatics, but integration of heterogeneous and often distributed tools and datasets can be challenging. To date, this challenge has been commonly addressed in a pragmatic way, by tedious and error-prone scripting. Recently however a more reliable technique has been identified and proposed as the platform that would tie together bioinformatics resources, namely Web Services. In the last decade the Web Services have spread wide in bioinformatics, and earned the title of recommended technology. However, in the era of high-throughput experimentation, a major concern regarding Web Services is their ability to handle large-scale data traffic. We propose a stream-like communication pattern for standard SOAP Web Services, that enables efficient flow of large data traffic between a workflow orchestrator and Web Services. We evaluated the data-partitioning strategy by comparing it with typical communication patterns on an example pipeline for genomic sequence annotation. The results show that data-partitioning lowers resource demands of services and increases their throughput, which in consequence allows to execute in-silico experiments on genome-scale, using standard SOAP Web Services and workflows. As a proof-of-principle we annotated an RNA-seq dataset using a plain BPEL workflow engine.
International Journal of Web Information Systems | 2013
Sattanathan Subramanian; Paweł Sztromwasser; Pål Puntervoll; Kjell Petersen
Purpose – eScience workflows use orchestration for integrating and coordinating distributed and heterogeneous scientific resources, which are increasingly exposed as web services. The rate of growth of scientific data makes eScience workflows data‐intensive, challenging existing workflow solutions. Efficient methods of handling large data in scientific workflows based on web services are needed. The purpse of this paper is to address this issue.Design/methodology/approach – In a previous paper the authors proposed Data‐Flow Delegation (DFD) as a means to optimize orchestrated workflow performance, focusing on SOAP web services. To improve the performance further, they propose pipelined data‐flow delegation (PDFD) for web service‐based eScience workflows in this paper, by leveraging from the domain of parallel programming. Briefly, PDFD allows partitioning of large datasets into independent subsets that can be communicated in a pipelined manner.Findings – The results show that the PDFD improves the executi...